首页> 外国专利> HUMAN COMPLEMENTARITY DETERMINING REGION (CDR) - GRAFTED ANTIBODY TO GANGLIOSIDE GM2

HUMAN COMPLEMENTARITY DETERMINING REGION (CDR) - GRAFTED ANTIBODY TO GANGLIOSIDE GM2

机译:人类互补决定区(CDR)-岗六糖苷GM2的抗体

摘要

A human CDR-grafted antibody which specifically reacts with ganglioside CM2, wherein said antibody comprises CDR 1, CDR 2 and CDR 3 of heavy chain (H chain) variable region (V region) comprising amino acid sequences described in SEQ ID NO:1, SEQ ID NO:2 and SEQ ID NO:3, and CDR 1, CDR 2 and CDR 3 of light chain (L chain) V region comprising amino acid sequences described in SEQ ID NO:4, SEQ ID NO: 5 and SEQ ID NO:6, and wherein at least one of the frameworks (FR) of said H chain and L chain V regions comprises an amino acid sequence selected from common sequences (HMECS; human most homologous consensus sequence) derived from human antibody subgroups.
机译:与神经节苷脂CM2特异性反应的人CDR移植抗体,其中所述抗体包含重链(H链)可变区(V区)的CDR 1,CDR 2和CDR 3,该重链包含SEQ ID NO:1中描述的氨基酸序列, SEQ ID NO:2和SEQ ID NO:3,以及轻链(L链)V区的CDR 1,CDR 2和CDR 3,其包含SEQ ID NO:4,SEQ ID NO:5和SEQ ID NO:2描述的氨基酸序列NO:6,并且其中所述H链和L链V区的至少一个框架(FR)包含选自人抗体亚组的共有序列(HMECS;人最同源共有序列)的氨基酸序列。

著录项

  • 公开/公告号CA2226400C

    专利类型

  • 公开/公告日2008-12-02

    原文格式PDF

  • 申请/专利权人 KYOWA HAKKO KOGYO CO. LTD.;

    申请/专利号CA19982226400

  • 发明设计人 NAKAMURA KAZUYASU;HANAI NOBUO;

    申请日1998-03-19

  • 分类号C12N15/13;A61K39/395;A61K51/10;A61P35;C07K16/30;C07K16/46;C12N5/10;C12P21/08;G01N33/574;G01N33/92;

  • 国家 CA

  • 入库时间 2022-08-21 19:23:40

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号